Who
Gorjan Hrustanovic
Director
Company insider
Files Form 4 as: Director, Kymera Therapeutics; Director, Olema Pharmaceuticals; Director, Rain Oncology.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 20 Aug 2020
- Last trade
- 24 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 25 Jun 2026 | KYMR Kymera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,068 at $0.00 | filing |
| 24 Jun 2026filed 25 Jun 2026 | KYMR Kymera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,068 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 25 Jun 2025filed 26 Jun 2025 | KYMR Kymera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,150 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | KYMR Kymera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 26 Jan 2024filed 26 Jan 2024 | Rain Oncologyoption or derivative | SEC FORM 4 Code D | —35,000 | filing |
| 26 Jan 2024filed 26 Jan 2024 | Rain Oncologyoption or derivative | SEC FORM 4 Code D | —20,000 | filing |
| 9 Aug 2023filed 11 Aug 2023 | Rain Oncologyoption or derivative | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 16 Jun 2023filed 21 Jun 2023 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | KYMR Kymera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 17 Jun 2022filed 27 Jun 2022 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
| 15 Jun 2022filed 16 Jun 2022 | KYMR Kymera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 1 Jun 2022filed 19 Aug 2022 | Rain Therapeuticsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Jun 2021filed 17 Jun 2021 | KYMR Kymera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,063 at $0.00 | filing |
| 9 Jun 2021filed 10 Jun 2021 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
| 18 Nov 2020filed 19 Nov 2020 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.